Bevacizumab and recurrent malignant gliomas: a European perspective
- PMID: 20159801
- DOI: 10.1200/JCO.2009.26.9027
Bevacizumab and recurrent malignant gliomas: a European perspective
Comment on
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720927 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

